Sandra Irenaeus

Potential gains from radical treatment of men with prostate cancer according to life expectancy

Irenaeus, Sandra; Garmo, Hans; Gedeborg, Rolf; Ahlberg, Mats et al.

Part of BJUI Compass, 2025

• DOI for Potential gains from radical treatment of men with prostate cancer according to life expectancy
• Download full text (pdf) of Potential gains from radical treatment of men with prostate cancer according to life expectancy

Changes in cancer incidence and stage during the COVID-19 pandemic in 2020-2021 in the Nordic countries

Johansson, Anna L. V.; Skog, Anna; Johannesen, Tom Børge; Myklebust, Tor Åge et al.

Part of Acta Oncologica, p. 257-266, 2025

• DOI for Changes in cancer incidence and stage during the COVID-19 pandemic in 2020-2021 in the Nordic countries
• Download full text (pdf) of Changes in cancer incidence and stage during the COVID-19 pandemic in 2020-2021 in the Nordic countries

Development and validation of a multi-dimensional diagnosis-based comorbidity index that improves prediction of death in men with prostate cancer: Nationwide, population-based register study

Westerberg, Marcus; Irenaeus, Sandra; Garmo, Hans; Stattin, Pär et al.

Part of PLOS ONE, 2024

• DOI for Development and validation of a multi-dimensional diagnosis-based comorbidity index that improves prediction of death in men with prostate cancer: Nationwide, population-based register study
• Download full text (pdf) of Development and validation of a multi-dimensional diagnosis-based comorbidity index that improves prediction of death in men with prostate cancer: Nationwide, population-based register study

Were cancer patients worse off than the general population during the COVID-19 pandemic?: A population-based study from Norway, Denmark and Iceland during the pre-vaccination era

Johansson, Anna L.; Skog, Anna; Johannesen, Tom Borge; Myklebust, Tor age et al.

Part of The Lancet Regional Health, 2023

• DOI for Were cancer patients worse off than the general population during the COVID-19 pandemic?: A population-based study from Norway, Denmark and Iceland during the pre-vaccination era
• Download full text (pdf) of Were cancer patients worse off than the general population during the COVID-19 pandemic?: A population-based study from Norway, Denmark and Iceland during the pre-vaccination era

Choice of imputation method for missing metastatic status affected estimates of metastatic prostate cancer incidence.

Westerberg, Marcus; Beckmann, Kerri; Gedeborg, Rolf; Irenaeus, Sandra et al.

Part of Journal of Clinical Epidemiology, p. 22-30, 2023

• DOI for Choice of imputation method for missing metastatic status affected estimates of metastatic prostate cancer incidence.
• Download full text (pdf) of Choice of imputation method for missing metastatic status affected estimates of metastatic prostate cancer incidence.

Potential gains from radical treatment of men with prostate cancer according to life expectancy

Irenaeus, Sandra; Garmo, Hans; Gedeborg, Rolf; Ahlberg, Mats et al.

Part of BJUI Compass, 2025

• DOI for Potential gains from radical treatment of men with prostate cancer according to life expectancy
• Download full text (pdf) of Potential gains from radical treatment of men with prostate cancer according to life expectancy

Changes in cancer incidence and stage during the COVID-19 pandemic in 2020-2021 in the Nordic countries

Johansson, Anna L. V.; Skog, Anna; Johannesen, Tom Børge; Myklebust, Tor Åge et al.

Part of Acta Oncologica, p. 257-266, 2025

• DOI for Changes in cancer incidence and stage during the COVID-19 pandemic in 2020-2021 in the Nordic countries
• Download full text (pdf) of Changes in cancer incidence and stage during the COVID-19 pandemic in 2020-2021 in the Nordic countries

Development and validation of a multi-dimensional diagnosis-based comorbidity index that improves prediction of death in men with prostate cancer: Nationwide, population-based register study

Westerberg, Marcus; Irenaeus, Sandra; Garmo, Hans; Stattin, Pär et al.

Part of PLOS ONE, 2024

• DOI for Development and validation of a multi-dimensional diagnosis-based comorbidity index that improves prediction of death in men with prostate cancer: Nationwide, population-based register study
• Download full text (pdf) of Development and validation of a multi-dimensional diagnosis-based comorbidity index that improves prediction of death in men with prostate cancer: Nationwide, population-based register study

Were cancer patients worse off than the general population during the COVID-19 pandemic?: A population-based study from Norway, Denmark and Iceland during the pre-vaccination era

Johansson, Anna L.; Skog, Anna; Johannesen, Tom Borge; Myklebust, Tor age et al.

Part of The Lancet Regional Health, 2023

• DOI for Were cancer patients worse off than the general population during the COVID-19 pandemic?: A population-based study from Norway, Denmark and Iceland during the pre-vaccination era
• Download full text (pdf) of Were cancer patients worse off than the general population during the COVID-19 pandemic?: A population-based study from Norway, Denmark and Iceland during the pre-vaccination era

Choice of imputation method for missing metastatic status affected estimates of metastatic prostate cancer incidence.

Westerberg, Marcus; Beckmann, Kerri; Gedeborg, Rolf; Irenaeus, Sandra et al.

Part of Journal of Clinical Epidemiology, p. 22-30, 2023

• DOI for Choice of imputation method for missing metastatic status affected estimates of metastatic prostate cancer incidence.
• Download full text (pdf) of Choice of imputation method for missing metastatic status affected estimates of metastatic prostate cancer incidence.

Intratumoral immunostimulatory AdCD40L gene therapy in patients with advanced solid tumors.

Irenaeus, Sandra; Hellström, Vivan; Wenthe, Jessica; Krause, Johan et al.

Part of Cancer Gene Therapy, p. 1188-1197, 2021

• DOI for Intratumoral immunostimulatory AdCD40L gene therapy in patients with advanced solid tumors.

Evaluation of Diffusion-Weighted MRI and FDG-PET/CT to Assess Response to AdCD40L treatment in Metastatic Melanoma Patients

Schiza, Aglaia; Irenaeus, Sandra; Ortiz-Nieto, Francisco; Loskog, Angelica S. et al.

Part of Scientific Reports, 2019

• DOI for Evaluation of Diffusion-Weighted MRI and FDG-PET/CT to Assess Response to AdCD40L treatment in Metastatic Melanoma Patients
• Download full text (pdf) of Evaluation of Diffusion-Weighted MRI and FDG-PET/CT to Assess Response to AdCD40L treatment in Metastatic Melanoma Patients

First-in-human study with intratumoral administration of a CD40 agonistic antibody, ADC-1013, in advanced solid malignancies

Irenaeus, Sandra; Nielsen, Dorte; Ellmark, Peter; Yachnin, Jeffrey et al.

Part of International Journal of Cancer, p. 1189-1199, 2019

• DOI for First-in-human study with intratumoral administration of a CD40 agonistic antibody, ADC-1013, in advanced solid malignancies

Local irradiation does not enhance the effect of immunostimulatory AdCD40L gene therapy combined with low dose cyclophosphamide in melanoma patients

Irenaeus, Sandra; Schiza, Aglaia; Mangsbo, Sara M.; Wenthe, Jessica et al.

Part of Oncotarget, p. 78573-78587, 2017

• DOI for Local irradiation does not enhance the effect of immunostimulatory AdCD40L gene therapy combined with low dose cyclophosphamide in melanoma patients
• Download full text (pdf) of Local irradiation does not enhance the effect of immunostimulatory AdCD40L gene therapy combined with low dose cyclophosphamide in melanoma patients

Gemcitabine reduces MDSCs, tregs and TGF beta-1 while restoring the teff/treg ratio in patients with pancreatic cancer

Eriksson, Emma; Wenthe, Jessica; Irenaeus, Sandra; Loskog, Angelica et al.

Part of Journal of Translational Medicine, 2016

• DOI for Gemcitabine reduces MDSCs, tregs and TGF beta-1 while restoring the teff/treg ratio in patients with pancreatic cancer
• Download full text (pdf) of Gemcitabine reduces MDSCs, tregs and TGF beta-1 while restoring the teff/treg ratio in patients with pancreatic cancer

Intratumoral CD40 stimulating therapy in patients with advanced cancer

Irenaeus, Sandra

2021

• Download full text (pdf) of Intratumoral CD40 stimulating therapy in patients with advanced cancer

Safety of intratumoral immunostimulatory LOAd703 gene therapy in patients with advanced cancer

Irenaeus, Sandra; Wenthe, Jessica; Eriksson, Emma; Schiza, Aglaia et al.

Different assumptions about missingness in registration of metastatic status have important implications for following trends in cancer presentation

Westerberg, Marcus; Beckman, Kerri; Gedeborg, Rolf; Irenaeus, Sandra et al.

Immunological evaluation of immunostimulatory gene therapy targeting CD40/4-1BB in advanced cancer patients (LOKON002)

Wenthe, Jessica; Eriksson, Emma; Naseri, Sedigheh; Sandin, Linda et al.